Dr. Christopher Awtrey, M.D

NPI: 1790792349
Total Payments
$439.40
2019 Payments
$400.00
Companies
3
Transactions
3
Medicare Patients
114
Medicare Billing
$3,477

Payment Breakdown by Category

Consulting$400.00 (91.0%)
Education$25.00 (5.7%)
Food & Beverage$14.40 (3.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $400.00 1 91.0%
Education $25.00 1 5.7%
Food and Beverage $14.40 1 3.3%

Top Paying Companies

Company Total Records Latest Year
Hologic, LLC $400.00 1 $0 (2019)
AMAG Pharmaceuticals, Inc. $25.00 1 $0 (2017)
Exelixis Inc. $14.40 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $400.00 1 Hologic, LLC ($400.00)
2017 $39.40 2 AMAG Pharmaceuticals, Inc. ($25.00)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/04/2019 Hologic, LLC Consulting Fee Cash or cash equivalent $400.00 General
09/29/2017 AMAG Pharmaceuticals, Inc. FERAHEME (Drug) Education In-kind items and services $25.00 General
Category: PARENTERAL IRON REPLACEMENT
01/20/2017 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $14.40 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 1 26 26 $3,068 $741.05
2020 2 88 94 $11,936 $2,736
Total Patients
114
Total Services
120
Medicare Billing
$3,477
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 26 26 $3,068 $741.05 24.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 21 25 $4,225 $990.40 23.4%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 42 43 $3,655 $904.50 24.7%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 25 26 $4,056 $840.76 20.7%

About Dr. Christopher Awtrey, M.D

Dr. Christopher Awtrey, M.D is a Gynecologic Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790792349.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Awtrey, M.D has received a total of $439.40 in payments from pharmaceutical and medical device companies, with $400.00 received in 2019. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($400.00).

As a Medicare-enrolled provider, Awtrey has provided services to 114 Medicare beneficiaries, totaling 120 services with total Medicare billing of $3,477. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Gynecologic Oncology
  • Location Boston, MA
  • Active Since 08/02/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207VX0201X
  • Entity Type Individual
  • NPI Number 1790792349

Products in Payments

  • FERAHEME (Drug) $25.00
  • Cabometyx (Drug) $14.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gynecologic Oncology Doctors in Boston